Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-25-000230
Filing Date
2025-03-27
Accepted
2025-03-27 15:16:43
Documents
76
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q aagh10q093024.htm   iXBRL 10-Q 669283
2 EXHIBIT 31.1 aaghex31-1.htm EX-31.1 9588
3 EXHIBIT 31.2 aaghex31-2.htm EX-31.2 13862
4 EXHIBIT 32.1 aaghex32-1.htm EX-32.1 4218
5 EXHIBIT 32.2 aaghex32-2.htm EX-32.2 5494
  Complete submission text file 0001185185-25-000230.txt   5236860

Data Files

Seq Description Document Type Size
6 XBRL CALCULATION FILE aagh-20240930_cal.xml EX-101.CAL 38421
7 XBRL DEFINITION FILE aagh-20240930_def.xml EX-101.DEF 246619
8 XBRL LABEL FILE aagh-20240930_lab.xml EX-101.LAB 417157
9 XBRL PRESENTATION FILE aagh-20240930_pre.xml EX-101.PRE 264854
10 XBRL SCHEMA FILE aagh-20240930.xsd EX-101.SCH 55292
79 EXTRACTED XBRL INSTANCE DOCUMENT aagh10q093024_htm.xml XML 603835
Mailing Address 1609 W VALLEY BLVD UNIT 338A ALHAMBRA CA 91803
Business Address 1609 W VALLEY BLVD UNIT 338A ALHAMBRA CA 91803 (888) 988-1333
America Great Health (Filer) CIK: 0001098009 (see all company filings)

EIN.: 980178621 | State of Incorp.: CA | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-27873 | Film No.: 25778993
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)